SESSION TITLE: Lung Cancer IV
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM
PURPOSE: Malignant pleural mesothelioma is an intractable malignancy with poor prognosis. For unresctable cases, the median survival by chemotherapy with cisplatin plus pemetrexed, is only one year. We tested the safety and effectiveness of intra-thoracic injectionof adenoviral vector expressing NK4 gene.